Table 1 Baseline clinical characteristics of subjects
Groups | Placebo | GCE | EGML |
|---|---|---|---|
N (male: female) | 29(15:14) | 29(15:14) | 28(16:12) |
Age (y) | 33.80 ± 2.97 | 34.07 ± 2.30 | 34.96 ± 2.42 |
Height (cm) | 169.63 ± 2.84 | 167.17 ± 1.58 | 167.95 ± 1.78 |
Body weight (kg) | 74.03 ± 3.03 | 71.09 ± 2.06 | 72.34 ± 1.92 |
BMI (kg/m2) | 25.53 ± 0.43 | 25.29 ± 0.36 | 25.25 ± 0.37 |
Systolic BP (mmHg) | 122.57 ± 4.49 | 125.69 ± 53 | 123.38 ± 4.02 |
Diasolic BP (mmHg) | 76.85 ± 2.65 | 74.11 ± 3.66 | 75.45 ± 3.84 |
FBG (mg/dL) | 90.04 ± 2.58 | 93.97 ± 3.44 | 88.73 ± 4.07 |
Waist (inch) | 33.43 ± 0.69 | 32.43 ± 0.60 | 33.49 ± 0.61 |
Hip (inch) | 39.49 ± 0.47 | 39.10 ± 0.42 | 39.54 ± 0.41 |